Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03187002
Other study ID # IRB-41589
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 18, 2018
Est. completion date October 31, 2019

Study information

Verified date October 2020
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

High-frequency, high-intensity transcutaneous electrical nerve-stimulation (TENS) is an inexpensive and non-invasive pain control approach. TENS, pulsating electrical currents that activate underlying nerves, does not have drug interactions or risk of overdose. Cochrane review of TENS for acute pain found inconclusive evidence. One previous abortion trial comparing TENS to IV sedation only looked at pain control in the recovery room. The investigators propose a randomized controlled trial comparing TENS to IV sedation (in conjunction with local anesthesia) among women presenting for first-trimester surgical abortion. Primary outcome will be perceived pain by Visual Analogue Scale (VAS) during aspiration.


Recruitment information / eligibility

Status Completed
Enrollment 109
Est. completion date October 31, 2019
Est. primary completion date October 31, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion criteria: - Presenting for surgical abortion - Gestational age <12 weeks - < 18 years of age - Agrees to be randomized Exclusion criteria: - Allergy to study medications (lidocaine, fentanyl, midazolam) - > 18 years of age - Fetal demise - Pre-procedure use of misoprostol - No means of transportation following procedure

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcutaneous electrical nerve stimulation (TENS)
Transcutaneous electrical nerve-stimulation (TENS) is a nonpharmacologic means of pain control that delivers electrical currents through the skin. These pulses of electrical current reduce pain by peripheral and central mechanisms, TENS actives descending inhibitory systems in the central nervous system to reduce sensitivity to pain (hypoalgesia). Assessment of previous TENS research identifies intensity as a critical factor in efficacy-documenting high intensity as the best means of pain control, as the higher pulse allows for deeper tissue afferents to be activated. TENS has been researched in a number of settings as pain control, including cancer pain, lower back pain, labor, and a range of gynecologic procedures and disorders.
Drug:
Moderate IV Sedation
IV sedation with fentanyl and versed
Other:
SHAM: Transcutaneous electrical nerve stimulation (TENS)
Sham Transcutaneous electrical nerve stimulation (TENS) to ensure blinding
SHAM: Moderate IV Sedation
Sham IV to ensure blinding

Locations

Country Name City State
United States Planned Parenthood Mar Monte San Jose California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Aspiration Pain Pain with aspiration, assessed by visual analogue scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") Intraoperative, collected during procedure at the time of aspiration (up to 30 seconds)
Secondary Speculum Placement Pain Pain with speculum placement, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") Intraoperative, collected during procedure (up to 30 seconds)
Secondary Tenaculum Placement Pain Pain at time of tenaculum placement, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") Intraoperative, collected during procedure (up to 30 seconds)
Secondary Paracervical Block Pain Pain with paracervical block, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") Intraoperative, collected during procedure (up to 30 seconds)
Secondary Manual Cervical Dilation Pain Pain with manual cervical dilation, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") Intraoperative, collected during procedure (up to 30 seconds)
Secondary Speculum Removal Pain Pain with speculum removal, assessed by visual analog scale (VAS, 0-100mm; 0 being "no pain" and 100 being "worst pain imaginable") Intraoperative, collected during procedure (up to 30 seconds)
Secondary Total Procedure Time Time from speculum placement to speculum removal, measured in minutes Intraoperative, collected during procedure (up to 20 minutes)
See also
  Status Clinical Trial Phase
Terminated NCT04056637 - Choice of Modality of Follow up for Medication Abortion N/A
Active, not recruiting NCT05896657 - Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713 N/A
Active, not recruiting NCT03736681 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage Phase 1
Completed NCT03636451 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o Phase 3
Completed NCT04446572 - Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin Phase 2
Not yet recruiting NCT03267771 - Progesterone and Doppler in Recurrent Abortion Phase 4
Recruiting NCT05341817 - The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy Phase 4
Completed NCT03079622 - Manual Versus Electric Vacuum Aspiration for Pregnancy Termination Between 10-14 Weeks N/A
Recruiting NCT05182008 - A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial N/A
Completed NCT03417362 - Delivery of Audiovisual Information on Early Medical Abortion N/A
Completed NCT03896022 - Auriculotherapy - Pain Management of Aspiration Abortion N/A
Completed NCT03925129 - Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation N/A
Suspended NCT03751423 - Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion Phase 3
Completed NCT03480009 - Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion Phase 3
Completed NCT05469594 - Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
Completed NCT05320432 - Transcutaneous Electrical Nerve Stimulation for Pain Control During First-trimester Abortion N/A
Terminated NCT04139382 - Using Telemedicine to Improve Early Medical Abortion at Home N/A
Recruiting NCT04956731 - Pharmacist Provision of Medication Abortion N/A
Recruiting NCT04336358 - Telemedicine for First Trimester Abortion in South Africa N/A
Completed NCT02096575 - Nitrous Oxide for Pain Management of First Trimester Surgical Abortion N/A